[1]
“COMPARATIVE ANALYSIS OF THE EFFECTIVENESS OF DAILY VERSUS INTERMITTENT ANTI-TUBERCULAR MEDICATION REGIMENS IN PATIENTS WITH CATEGORY 1 TUBERCULOSIS”, Int. Res. J. Pharm., vol. 11, no. 9, pp. 39–42, Nov. 2024, Accessed: Oct. 31, 2026. [Online]. Available: https://irjponline.org/index.php/irjp/article/view/576